LUCD 8-K 2026-11-12

Lucid Diagnostics Inc. (LUCD) 8-K dated 2026-11-12 — accession 0001493152-26-051207.

Lucid Diagnostics Inc. (LUCD) is a medical devices company listed on US.

Lucid Diagnostics Inc. filed a 8-K on 2026-11-12. Accession 0001493152-26-051207.

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LUCD revenue for 2025-12-31 was $4.7M. Net income was -$58.0M. Revenue was up 8.3% from 2024-12-31 to 2025-12-31. LUCD currently screens at market cap $123.3M.

Not investment advice. The LUCD SEC hub lists recent forms. The stock page is the research view.